Actual Medicinal Product (AMP) Malarone 250mg/100mg tablets (Mawdsley-Brooks & Company Ltd)
This product can't be added to an MCA list.
Stability Information
(Some stability information inherited from generic)
- Stability
-
Suitable for use in MCAs, although use is likely to be off-label. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
- Notes
-
No special precautions for storage.
- Provenance
-
This compatibility recommendation is derived from Malarone 250mg/100mg tablets (GlaxoSmithKline UK Ltd).
- Generic
- Proguanil + Atovaquone
- Formulation
- Proguanil 100mg / Atovaquone 250mg tablets
-
Proguanil + Atovaquone
-
Proguanil 100mg / Atovaquone 250mg tablets
-
Malarone 250mg/100mg tablets (Mawdsley-Brooks & Company Ltd)
-
-
Proguanil 25mg / Atovaquone 62.5mg tablets